Home»Exposition»New Late-Breaking Analyses from Landmark COAPT™ Trial Show Benefits of Abbott’s MitraClip™ Device

New Late-Breaking Analyses from Landmark COAPT™ Trial Show Benefits of Abbott’s MitraClip™ Device

0
Shares
Pinterest Google+
New Late-Breaking Analyses from Landmark COAPT™ Trial Show Benefits of Abbott's MitraClip™ Device

NEW ORLEANS, March 17, 2019 /PRNewswire/ — Abbott (NYSE: ABT) today announced positive late-breaking data from two separate analyses of the COAPT™ Trial showing additional key benefits from treatment with MitraClip™ for heart failure patients with clinically significant secondary (or…

Previous post

Superstars Lionel Richie, Shania Twain, Snoop Dogg and More Appear at Keep Memory Alive's 23rd Annual Power of Love® Gala

Next post

EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Bridgepoint Education, Inc. - BPI